FDA Scrutiny of AI Tools Parallels Ivermectin Policy Divide

adicionou um novo artigo Health

2025-09-16 10:44:31

As the healthcare industry evolves, federal oversight is increasingly challenged to keep pace with innovation. The FDA has begun reviewing AI mental health tools for safety and efficacy, marking a critical step in regulating emerging technology. At the same time, Ivermectin policies continue to provoke debate, highlighting longstanding tensions around medical oversight, public trust,...

0 Comentários 0 Compartilhamentos 34 Visualizações 0 Anterior